Literature DB >> 27796662

Genetic variant of IL-10RA and susceptibility to rheumatoid arthritis in a Chinese population.

Xiao-Ke Yang1,2, Peng Li1,2, Song Li3, Chao Zhang1,2, Bao-Zhu Li1,2, Rui-Xue Leng1,2, Hai-Feng Pan1,2, Dong-Qing Ye4,5.   

Abstract

The aim of this study was to investigate the relationship between the single-nucleotide polymorphisms (SNPs) of interleukin 10 alpha receptor (IL10RA) gene and rheumatoid arthritis (RA) in a Chinese population. We examined 533 RA patients and 958 subjects as a control group. Three IL-10RA SNPs (rs9610, rs2229113 and rs3135932) were genotyped using TaqMan genotyping assays on Fluidigm 192.24 system. The IL-10RA rs9610 A allele was increased in patient group compared with control subjects (OR = 1.232, 95 % CI = 1.052-1.442, p = 0.030). Significant difference in genotype distribution was found in RA patients and controls (χ2 = 15.32, p < 0.001). We also discovered a statistical significance under the dominant model (GG + AG versus AA: OR = 0.676, 95 % CI = 0.546-0.837, p < 0.001). However, no significant difference was discovered in the recessive model (GG versus AG + AA: OR = 1.013, 95 % CI = 0.754-1.361, p = 0.932). Interestingly, significant differences were detected both in the allele and genotype frequencies of rs9610 between anti-CCP positive patients and anti-CCP negative patients (χ2 = 7.209, p = 0.007; χ2 = 9.061, p = 0.011; respectively). We also found a significant difference in genotype frequency at rs9610 in females compared with males (χ2 = 7.658, p = 0.022). Unfortunately, we failed to find any significant results between two IL-10RA SNPs (rs2229113 and rs3135932) and RA susceptibility. The findings suggest that IL-10RA rs9610 polymorphism might contribute to RA susceptibility.

Entities:  

Keywords:  Interleukin 10 alpha receptor; Rheumatoid arthritis; Single nucleotide polymorphism

Mesh:

Substances:

Year:  2016        PMID: 27796662     DOI: 10.1007/s10067-016-3449-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  27 in total

1.  Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins.

Authors:  A J MacGregor; H Snieder; A S Rigby; M Koskenvuo; J Kaprio; K Aho; A J Silman
Journal:  Arthritis Rheum       Date:  2000-01

2.  Genetic polymorphisms in IL10RA and TNF modify the association between blood transfusion and risk of non-Hodgkin lymphoma.

Authors:  Xiaofeng Bi; Tongzhang Zheng; Qing Lan; Zhijian Xu; Yingtai Chen; Gongjian Zhu; Francine Foss; Christopher Kim; Min Dai; Ping Zhao; Theodore Holford; Brian Leaderer; Peter Boyle; Qian Deng; Stephen J Chanock; Nathaniel Rothman; Yawei Zhang
Journal:  Am J Hematol       Date:  2012-05-31       Impact factor: 10.047

Review 3.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 4.  The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes.

Authors:  R P Donnelly; H Dickensheets; D S Finbloom
Journal:  J Interferon Cytokine Res       Date:  1999-06       Impact factor: 2.607

5.  Conformational changes mediate interleukin-10 receptor 2 (IL-10R2) binding to IL-10 and assembly of the signaling complex.

Authors:  Sung Il Yoon; Naomi J Logsdon; Faruk Sheikh; Raymond P Donnelly; Mark R Walter
Journal:  J Biol Chem       Date:  2006-09-18       Impact factor: 5.157

Review 6.  Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus.

Authors:  Hui Peng; Wei Wang; Mo Zhou; Rui Li; Hai-Feng Pan; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2013-05-25       Impact factor: 2.980

7.  Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis.

Authors:  Jonathan C W Edwards; Leszek Szczepanski; Jacek Szechinski; Anna Filipowicz-Sosnowska; Paul Emery; David R Close; Randall M Stevens; Tim Shaw
Journal:  N Engl J Med       Date:  2004-06-17       Impact factor: 91.245

8.  Comparison of interleukin-22 and interleukin-10 soluble receptor complexes.

Authors:  Naomi J Logsdon; Brandi C Jones; Kristopher Josephson; Jennifer Cook; Mark R Walter
Journal:  J Interferon Cytokine Res       Date:  2002-11       Impact factor: 2.607

9.  In vivo pro- and anti-inflammatory cytokines in normal and patients with rheumatoid arthritis.

Authors:  Suppiah Paramalingam Sivalingam; Julian Thumboo; Sheila Vasoo; Szu Tien Thio; Connie Tse; Kok Yong Fong
Journal:  Ann Acad Med Singapore       Date:  2007-02       Impact factor: 2.473

10.  Potential of modulatory cytokines in the rheumatoid arthritis process.

Authors:  E Lubberts; W B van den Berg
Journal:  Drug News Perspect       Date:  2001-11
View more
  2 in total

1.  Red blood cell distribution width: a potential laboratory parameter for monitoring inflammation in rheumatoid arthritis.

Authors:  Yujue He; Can Liu; Zhiyong Zeng; Weilin Ye; Jinpiao Lin; Qishui Ou
Journal:  Clin Rheumatol       Date:  2017-11-03       Impact factor: 2.980

2.  T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation-Updated Consensus and Review 2020.

Authors:  Vibha Jawa; Frances Terry; Jochem Gokemeijer; Shibani Mitra-Kaushik; Brian J Roberts; Sophie Tourdot; Anne S De Groot
Journal:  Front Immunol       Date:  2020-06-30       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.